| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.004 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.006 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.006 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.008 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.009 |